Report ID: GIR2101300260 | Category: New Technology | Pages: 120 | Format: PDF | Published Date: July 29,2021
1 Market Overview
1.1 Product Overview and Scope of NGS-Based Monitoring and Diagnostic Test
1.2 Classification of NGS-Based Monitoring and Diagnostic Test by Type
1.2.1 Overview: Global NGS-Based Monitoring and Diagnostic Test Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type in 2020
1.2.3 Commercial Assays/Tests
1.2.4 Laboratory Developed Tests
1.2.5 Direct to Consumer Test
1.2.6 Pre-Commercial Tests
1.3 Global NGS-Based Monitoring and Diagnostic Test Market by Application
1.3.1 Overview: Global NGS-Based Monitoring and Diagnostic Test Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Out-Patient Clinics/General Practitioners
1.3.3 Diagnostic Centers
1.3.4 Hospitals
1.3.5 Others
1.4 Global NGS-Based Monitoring and Diagnostic Test Market Size & Forecast
1.5 Global NGS-Based Monitoring and Diagnostic Test Market Size and Forecast by Region
1.5.1 Global NGS-Based Monitoring and Diagnostic Test Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global NGS-Based Monitoring and Diagnostic Test Market Size by Region, (2016-2021)
1.5.3 North America NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)
1.5.4 Europe NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)
1.5.6 South America NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa NGS-Based Monitoring and Diagnostic Test Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 NGS-Based Monitoring and Diagnostic Test Market Drivers
1.6.2 NGS-Based Monitoring and Diagnostic Test Market Restraints
1.6.3 NGS-Based Monitoring and Diagnostic Test Trends Analysis
2 Company Profiles
2.1 Agilent Technologies, Inc.
2.1.1 Agilent Technologies, Inc. Details
2.1.2 Agilent Technologies, Inc. Major Business
2.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.1.4 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.2 Ancestry.com LLC
2.2.1 Ancestry.com LLC Details
2.2.2 Ancestry.com LLC Major Business
2.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.2.4 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Ancestry.com LLC Recent Developments and Future Plans
2.3 ArcherDX, Inc.
2.3.1 ArcherDX, Inc. Details
2.3.2 ArcherDX, Inc. Major Business
2.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.3.4 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 ArcherDX, Inc. Recent Developments and Future Plans
2.4 Beijing Genomics Institute (BGI)
2.4.1 Beijing Genomics Institute (BGI) Details
2.4.2 Beijing Genomics Institute (BGI) Major Business
2.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.4.4 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Beijing Genomics Institute (BGI) Recent Developments and Future Plans
2.5 Cancer Genetics, Inc.
2.5.1 Cancer Genetics, Inc. Details
2.5.2 Cancer Genetics, Inc. Major Business
2.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.5.4 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Cancer Genetics, Inc. Recent Developments and Future Plans
2.6 CENTOGENE AG
2.6.1 CENTOGENE AG Details
2.6.2 CENTOGENE AG Major Business
2.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.6.4 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 CENTOGENE AG Recent Developments and Future Plans
2.7 F. Hoffmann-La Roche Ltd
2.7.1 F. Hoffmann-La Roche Ltd Details
2.7.2 F. Hoffmann-La Roche Ltd Major Business
2.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.7.4 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.8 GenePath Dx
2.8.1 GenePath Dx Details
2.8.2 GenePath Dx Major Business
2.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.8.4 GenePath Dx NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GenePath Dx Recent Developments and Future Plans
2.9 Illumina, Inc.
2.9.1 Illumina, Inc. Details
2.9.2 Illumina, Inc. Major Business
2.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.9.4 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Illumina, Inc. Recent Developments and Future Plans
2.10 Laboratory Corporation of America Holdings
2.10.1 Laboratory Corporation of America Holdings Details
2.10.2 Laboratory Corporation of America Holdings Major Business
2.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.10.4 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.11 Myriad Genetics, Inc.
2.11.1 Myriad Genetics, Inc. Details
2.11.2 Myriad Genetics, Inc. Major Business
2.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.11.4 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Myriad Genetics, Inc. Recent Developments and Future Plans
2.12 QIAGEN N.V.
2.12.1 QIAGEN N.V. Details
2.12.2 QIAGEN N.V. Major Business
2.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.12.4 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 QIAGEN N.V. Recent Developments and Future Plans
2.13 Quest Diagnostics Incorporated
2.13.1 Quest Diagnostics Incorporated Details
2.13.2 Quest Diagnostics Incorporated Major Business
2.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.13.4 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
2.14 Siemens Healthineers, Inc.
2.14.1 Siemens Healthineers, Inc. Details
2.14.2 Siemens Healthineers, Inc. Major Business
2.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.14.4 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Siemens Healthineers, Inc. Recent Developments and Future Plans
2.15 Thermo Fisher Scientific Inc.
2.15.1 Thermo Fisher Scientific Inc. Details
2.15.2 Thermo Fisher Scientific Inc. Major Business
2.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.15.4 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.16 HTG Molecular Diagnostics, Inc.
2.16.1 HTG Molecular Diagnostics, Inc. Details
2.16.2 HTG Molecular Diagnostics, Inc. Major Business
2.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.16.4 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 HTG Molecular Diagnostics, Inc. Recent Developments and Future Plans
2.17 Vela Diagnostics Pte. Ltd.
2.17.1 Vela Diagnostics Pte. Ltd. Details
2.17.2 Vela Diagnostics Pte. Ltd. Major Business
2.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product and Solutions
2.17.4 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Vela Diagnostics Pte. Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global NGS-Based Monitoring and Diagnostic Test Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 NGS-Based Monitoring and Diagnostic Test Players Market Share
3.2.2 Top 10 NGS-Based Monitoring and Diagnostic Test Players Market Share
3.2.3 Market Competition Trend
3.3 NGS-Based Monitoring and Diagnostic Test Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global NGS-Based Monitoring and Diagnostic Test Revenue and Market Share by Type (2016-2021)
4.2 Global NGS-Based Monitoring and Diagnostic Test Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Application (2016-2021)
5.2 NGS-Based Monitoring and Diagnostic Test Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2026)
6.2 North America NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2026)
6.3 North America NGS-Based Monitoring and Diagnostic Test Market Size by Country
6.3.1 North America NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2026)
6.3.2 United States NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
6.3.3 Canada NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
6.3.4 Mexico NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2026)
7.2 Europe NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2026)
7.3 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country
7.3.1 Europe NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2026)
7.3.2 Germany NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
7.3.3 France NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
7.3.4 United Kingdom NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
7.3.5 Russia NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
7.3.6 Italy NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2026)
8.2 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2026)
8.3 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Region
8.3.1 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Revenue by Region (2016-2026)
8.3.2 China NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
8.3.3 Japan NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
8.3.4 South Korea NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
8.3.5 India NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
8.3.7 Australia NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2026)
9.2 South America NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2026)
9.3 South America NGS-Based Monitoring and Diagnostic Test Market Size by Country
9.3.1 South America NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2026)
9.3.2 Brazil NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
9.3.3 Argentina NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Type (2016-2026)
10.2 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Application (2016-2026)
10.3 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size by Country
10.3.1 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Revenue by Country (2016-2026)
10.3.2 Turkey NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
10.3.4 UAE NGS-Based Monitoring and Diagnostic Test Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
It contains all the geographic trends, and market analysis for global market